-
As if we didn't already have enough privacy and security concerns to worry about, the medical device industry must add one more to the "not absolutely secure" list. A team of researchers has demonstrated that devices monitored by telemetry can be disrupted wirelessly thus, essentially hackable.
-
A commonly used medication that prevents blood clots from forming may also prevent existing clots from damaging delicate vein walls and may accelerate healing in a clot-damaged area of vein wall, according to new research from the University of Michigan (U-M) Cardiovascular Center (Ann Arbor, Michigan).
-
Stroke, besides being the third leading cause of death in the U.S., also can claim an impressive number of stroke drugs. Clinical trial failures number in the dozens. And preventive possibilities remain about equally slim.
-
InspireMD (Tel Aviv, Israel) reported that it has launched the MGuard Coronary Stent in Italy. MGuard received CE-mark approval in October to treat patients with coronary artery diseases. Distribution of MGuard in Italy will be carried out by InspireMD's Italian distributor, Kardia (Milan).
-
BG Medicine; ACS Biomarker; Cardiovascular Research Institute Maastricht; Medrad; Bayer HealthCare; Possis Medical; Merit Medical Systems; Micrus Endovascular; Mindray Medical International; Datascope; Nfocus Neuromedical; Acta Vascular Systems
-
Full prescription coverage of heart drugs could help heart attack survivors live longer and lower the nation's healthcare costs, according to an analysis reported in Circulation: Journal of the American Heart Association.
-
Advanced Cell Technology; Cordis; Angiotech Pharmaceuticals; Rex Medical; Aporo Biomedical; mNemoscience; Cardiac Science; CH2M HILL; Cummins Engine; Colubris Networks; Cardiac Science; Premier Purchasing Partners; Atrium Medical; W.L. Gore & Associates
-
As the saying goes, sometimes no decision is a decision, and such was the case in last week's announcement by the Centers for Medicare & Medicaid Services to make no change to its current payment policy for computerized tomography for angiography (CTA).
-
Biophan Technologies; CryoCath Technologies; Edwards Lifesciences; ev3; Naviscan PET Systems; NewCardio; Omron Healthcare; Spectranetics
-
Dr. Rolf Kaese, chief executive of Berlin Heart (Berlin), is resigning from the company, citing strategy differences with Syscore (London), which acquired the company in October 2006.
